Undervalued Biotechnology Stocks on TSX November 2023

November 12, 2023

Biotechnology

Biotechnology and Biopharmaceutical companies are engaged in research, discovery, development, and production of innovative drug and drug-related technologies.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Biotechnology stocks

Stocks in this category are held primarily for capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
PSYB PsyBio Therapeutics 0.01 0.02 342.46 48960 1 0.00 0.0
SVS Solarvest BioEnergy 0.03 0.08 208.12 - 2 0.00 0.0
MSCL Satellos Bioscience 0.31 0.66 113.28 47145 24 0.00 0.0
HEM Hemostemix 0.07 0.13 71.64 81239 6 0.00 0.0
XRTX XORTX Therapeutics 0.38 0.62 62.86 54109 1 0.00 0.0
MRVL Marvel Biosciences 0.06 0.10 62.04 24351 2 0.00 0.0
KNE Kane Biotech 0.06 0.09 58.17 27315 7 0.00 0.0
RP RepliCel Life Sciences 0.07 0.10 47.57 18392 4 0.00 0.0
CZO Ceapro 0.28 0.39 40.81 38370 22 0.00 0.0
BTI Bioasis Technologies 0.01 0.01 34.44 3334 0 0.00 0.0
All data provided as at market close November 09, 2023.

Company Details

PsyBio Therapeutics

PSYB:TSX-V

Close Price

0.01

Our Valuation

0.02

% Difference

342.46

Market Cap ($M)

1

P/E Ratio

0.0

PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

Access the stockcalc valuation


Solarvest BioEnergy

SVS:TSX-V

Close Price

0.03

Our Valuation

0.08

% Difference

208.12

Market Cap ($M)

2

P/E Ratio

0.0

Solarvest BioEnergy Inc is a Canada based algae biologics company whose production platform provides flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has also initiated a program for the expression of CBD and THC to be produced in GMP fermentation facilities.

Access the stockcalc valuation


Satellos Bioscience

MSCL:TSX-V

Close Price

0.31

Our Valuation

0.66

% Difference

113.28

Market Cap ($M)

24

P/E Ratio

0.0

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Access the stockcalc valuation


Hemostemix

HEM:TSX-V

Close Price

0.07

Our Valuation

0.13

% Difference

71.64

Market Cap ($M)

6

P/E Ratio

0.0

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

XORTX Therapeutics

XRTX:TSX-V

Close Price

0.38

Our Valuation

0.62

% Difference

62.86

Market Cap ($M)

1

P/E Ratio

0.0

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection.

Access the stockcalc valuation


Marvel Biosciences

MRVL:TSX-V

Close Price

0.06

Our Valuation

0.10

% Difference

62.04

Market Cap ($M)

2

P/E Ratio

0.0

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known proven drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis.

Access the stockcalc valuation


Kane Biotech

KNE:TSX-V

Close Price

0.06

Our Valuation

0.09

% Difference

58.17

Market Cap ($M)

7

P/E Ratio

0.0

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business.

Access the stockcalc valuation


RepliCel Life Sciences

RP:TSX-V

Close Price

0.07

Our Valuation

0.10

% Difference

47.57

Market Cap ($M)

4

P/E Ratio

0.0

RepliCel Life Sciences Inc is a Canadian regenerative medicine company. It focuses on developing autologous cell therapies that treat functional cellular deficits. The company addresses various diseases such as chronic tendon injuries, androgenetic alopecia, and skin aging. Its development program of the company is based on distinct technology that utilizes cells isolated from a patient's healthy hair follicles.

Access the stockcalc valuation


Ceapro

CZO:TSX-V

Close Price

0.28

Our Valuation

0.39

% Difference

40.81

Market Cap ($M)

22

P/E Ratio

0.0

Ceapro Inc is engaged in the development and marketing of various health and wellness products and technology relating to plant extracts. Its operating segment is the active ingredient product technology industry which involves the development of proprietary extraction technologies and the application of these technologies to the production and development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries.

Access the stockcalc valuation


Bioasis Technologies

BTI:TSX-V

Close Price

0.01

Our Valuation

0.01

% Difference

34.44

Market Cap ($M)

0

P/E Ratio

0.0

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
PsyBio Therapeutics and Solarvest BioEnergy are the most undervalued Biotechnology stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-biotechnology-stocks-tsx-november-2023
PsyBio Therapeutics $PSYB and Solarvest BioEnergy $SVS are the most undervalued Biotechnology stocks on the #TSX. See the full list: https://www.stockcalc.com/Blog/undervalued-biotechnology-stocks-tsx-november-2023
PsyBio Therapeutics and Solarvest BioEnergy are the most undervalued Biotechnology stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-biotechnology-stocks-tsx-november-2023

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.